Ankara Sehir Hastanesi

Ankara 06800

1 studies enrolling now · 3 studies all time

What they study most

HER2 Exon 20 Mutation, Metastatic Urothelial Cancer, Non-squamous NSCLC, Primary Biliary Cholangitis

Studies at this site

• Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Recruiting now
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed